Delivery Order SPE2DB24D2018-SPE2DB25FWWA1
Award Date 8/4/25
Potential Completion Date 8/25/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tavalisse 100 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $18,533.40 and an ultimate completion date of August 12, 2025. The award represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. Tavalisse is a pharmaceutical product used in the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,296.97 firm fixed-price delivery order is for the supply of TAVALISSE 150 MG TABLET 60S, a medication, with a completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award, valued at $9,266.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product, with a completion date of June 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,364,728 units of the TAVALISSE 100 MG tablet drug product. The contract has a firm-fixed price of $8,574.23 and an ultimate completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award, valued at $9,296.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a...
- This is a $9,266.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAVALISSE 100 MG TABLET 60S, a medical product, with a performance period ending on July 8, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,296.97 firm fixed-price delivery order is for the provision of TAVALISSE 150 MG TABLET 60S, with a period of performance through February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,870.56 firm-fixed-price delivery order is for the supply of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAVALISSE 150 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $17,099.40 and a period of performance through September 2024. There is no set-aside designation for this award....